JP2023524445A5 - - Google Patents
Info
- Publication number
- JP2023524445A5 JP2023524445A5 JP2022565804A JP2022565804A JP2023524445A5 JP 2023524445 A5 JP2023524445 A5 JP 2023524445A5 JP 2022565804 A JP2022565804 A JP 2022565804A JP 2022565804 A JP2022565804 A JP 2022565804A JP 2023524445 A5 JP2023524445 A5 JP 2023524445A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence shown
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026034125A JP2026077893A (ja) | 2020-04-29 | 2026-03-04 | 医薬製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063017061P | 2020-04-29 | 2020-04-29 | |
| US63/017,061 | 2020-04-29 | ||
| PCT/US2021/029545 WO2021222347A1 (en) | 2020-04-29 | 2021-04-28 | Pharmaceutical formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026034125A Division JP2026077893A (ja) | 2020-04-29 | 2026-03-04 | 医薬製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524445A JP2023524445A (ja) | 2023-06-12 |
| JP2023524445A5 true JP2023524445A5 (cg-RX-API-DMAC10.html) | 2024-03-28 |
Family
ID=76099008
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022565804A Pending JP2023524445A (ja) | 2020-04-29 | 2021-04-28 | 医薬製剤 |
| JP2026034125A Pending JP2026077893A (ja) | 2020-04-29 | 2026-03-04 | 医薬製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026034125A Pending JP2026077893A (ja) | 2020-04-29 | 2026-03-04 | 医薬製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230167176A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4142789A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP2023524445A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230004798A (cg-RX-API-DMAC10.html) |
| CN (1) | CN115461080A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021265108A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3173934A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL297081A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021222347A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202415407A (zh) * | 2022-06-30 | 2024-04-16 | 中國大陸商蘇州創勝醫藥集團有限公司 | 穩定之包含抗cldn18.2抗體的藥物製劑 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| JPH02500329A (ja) | 1987-05-21 | 1990-02-08 | クリエイテイブ・バイオマリキユールズ・インコーポレーテツド | ターゲット化多機能蛋白質 |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| AU2001264946A1 (en) | 2000-05-24 | 2001-12-03 | Imclone Systems Incorporated | Bispecific immunoglobulin-like antigen binding proteins and method of production |
| EP1786918A4 (en) | 2004-07-17 | 2009-02-11 | Imclone Systems Inc | NEW BISPECIFIC ANTIBODY TETRAVALENT |
| CA2697922A1 (en) | 2007-08-28 | 2009-03-12 | Biogen Idec Ma Inc. | Compositions that bind multiple epitopes of igf-1r |
| PE20151179A1 (es) * | 2012-11-01 | 2015-09-12 | Abbvie Inc | Inmunoglobulinas de dominio variable dual anti-vegf/dll4 y usos de las mismas |
| US12065482B2 (en) * | 2016-08-10 | 2024-08-20 | Celltrion Inc. | Stable liquid pharmaceutical formulation of anti-influenza virus antibody |
| CR20190408A (es) | 2017-02-02 | 2020-01-31 | Amgen Inc | Composición farmacéutica de bajo ph que comprende construcciones de anticuerpos que activan linfocitos t antecedentes |
| MA48763A (fr) * | 2017-05-05 | 2020-04-08 | Amgen Inc | Composition pharmaceutique comprenant des constructions d'anticorps bispécifiques pour un stockage et une administration améliorés |
| KR20200036889A (ko) * | 2017-07-28 | 2020-04-07 | 에프. 호프만-라 로슈 아게 | 이중특이성 항체 제형 |
-
2021
- 2021-04-28 IL IL297081A patent/IL297081A/en unknown
- 2021-04-28 KR KR1020227041361A patent/KR20230004798A/ko active Pending
- 2021-04-28 CN CN202180030938.6A patent/CN115461080A/zh active Pending
- 2021-04-28 JP JP2022565804A patent/JP2023524445A/ja active Pending
- 2021-04-28 US US17/921,794 patent/US20230167176A1/en active Pending
- 2021-04-28 CA CA3173934A patent/CA3173934A1/en active Pending
- 2021-04-28 WO PCT/US2021/029545 patent/WO2021222347A1/en not_active Ceased
- 2021-04-28 EP EP21727965.2A patent/EP4142789A1/en active Pending
- 2021-04-28 AU AU2021265108A patent/AU2021265108A1/en active Pending
-
2026
- 2026-03-04 JP JP2026034125A patent/JP2026077893A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10954303B2 (en) | Immunoglobulin formulation and method of preparation thereof | |
| JP7057360B2 (ja) | 抗－ｃｄ３抗体製剤 | |
| US5932223A (en) | Rotavirus vaccine formulations | |
| US20190071496A1 (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| US6616931B1 (en) | Rotavirus vaccine formulations | |
| JP2022095697A (ja) | 抗ｒｓｖモノクローナル抗体製剤 | |
| US6403098B1 (en) | Rotavirus vaccine formulations | |
| EP2892504B1 (fr) | Solution aqueuse de protéine à concentration élevée de viscosité réduite | |
| KR20090021298A (ko) | 항-ｅｇｆｒ 항체의 동결건조 제제 | |
| JP2013511557A5 (cg-RX-API-DMAC10.html) | ||
| US12251474B2 (en) | Process for lyophilized pharmaceutical formulations of a therapeutic protein | |
| WO2023280152A1 (en) | Combination therapy for treatment of liver diseases | |
| JP2021506922A5 (cg-RX-API-DMAC10.html) | ||
| JP2026062740A (ja) | 安定した抗ｐｄ－１抗体の薬剤学的製剤 | |
| EP0939648B1 (en) | Rotavirus vaccine formulations | |
| JP2022513684A5 (cg-RX-API-DMAC10.html) | ||
| AU2015243993A1 (en) | Stable formulations for anti-CD19 antibodies and antibody-drug conjugates | |
| JP2023538669A5 (cg-RX-API-DMAC10.html) | ||
| US20260069688A1 (en) | Stable antibody composition | |
| JP2023524444A5 (cg-RX-API-DMAC10.html) | ||
| JP7085482B2 (ja) | スタフィロコッカス感染症のための凍結乾燥製剤を製造する方法 | |
| US20220257702A1 (en) | Stable albuvirtide compositions | |
| KR20230167968A (ko) | 점도 감소 부형제 조성물 및 이를 포함하는 저점도 고농축 단백질 제형 | |
| JP2023501155A5 (cg-RX-API-DMAC10.html) | ||
| JP2022545553A5 (cg-RX-API-DMAC10.html) |